Table 1.
Latin name | Polysaccharide | Models | Dose and period | Diabetic and related Complications | Possible mechanisms | Year/References |
---|---|---|---|---|---|---|
Auricularia auricula | AAP; crude polysaccharide |
Intraperitoneal injection of 30 mg/kg STZ in male SD rats for 3 days | 100 and 400 mg/kg for 4 weeks | Antidiabetic and antinephritic effects | Modulation of the antioxidative system and NF-κB-related signaling | 2017 (Hu et al., 2017) |
Flammulina velutipes | Ac-RPS, Al-RPS and En-RPS; monosaccharide composition analysis |
Three successive intraperitoneal injections of 80 mg/kg STZ in male Kunming mice | 200, 400 and 800 mg/kg for 15 days | Antioxidant abilities and protective effects against kidney damage | Serum CRE, BUN, ALB, GLU and renal MDA levels (↓); renal SOD, CAT and GSH-Px levels (↑); alleviation of kidney damage | 2016 (Lin et al., 2016) |
Pleurotus djamor | Ac-MZPS, Al-MZPS and En-MZPS; acidic-, alkalic- and enzymatic-extractable mycelium zinc polysaccharides |
Intraperitoneal injection of 120 mg/kg STZ in Kunming mice for 5 days | 200, 400 and 800 mg/kg for 2 weeks | Antioxidant abilities and protective effects against kidney and liver damage | SOD, GSH-Px and CAT levels (↑); MDA, ALT, AST, BUN, CRE, TC, LDL-C and HDL-C levels (↓); alleviation of liver and kidney injury | 2015 (Zhang et al., 2015) |
Trametes versicolor (L.:Fr.) Pilát (also known as Yunzhi) | TVP LH-1ePSP; monosaccharide composition analysis |
Injection of 65 mg/kg STZ via the tail vein in male Wistar rats for 5 days | 100 mg/kg for 28 days | Beneficial effects on bone microarchitecture and bone quality in a DM-induced bone-loss model | Protection of bone properties in part through improvement of hyperglycemic control | 2015 (Chen et al., 2015) |
Pleurotus tuber-regium | HP, MP and LP; extracellular polysaccharides |
Intraperitoneal injection of 10 mg/kg STZ along with 30 mg/kg nicotinamide every other day for 6 weeks | 20 mg/kg for 8 weeks | Attenuation of obesity/diabetes-induced adverse effects through the maintenance of stable fatty acid composition and reversal of obesity and hyperlipidemia | Support of upegulated hepatic PPAR-α mRNA and protein levels and antihyperglycemic properties | 2014 (Huang et al., 2014) |
Ganoderma lucidum | G1-PS; crude polysaccharide |
Single injection of 65 mg/kg STZ in SD rats | 20 mg/kg for 8 weeks | Hypoglycemic effect | Prevention of apoptosis of pancreatic β-cells and enhancement of β-cell regeneration | 2012 (Zheng et al., 2012) |
G1-PS; crude polysaccharide |
Intraperitoneal injection of 60 mg/kg STZ in male C57BL/6 mice for 5 days | 10 mg/kg, 50 mg/kg and 250 mg/kg | Rescue of delayed wound healing and improvement of wound angiogenesis | Suppression of cutaneous MnSOD nitration, p66Shc and mitochondrial oxidative stress | 2012 (Tie et al., 2012) |
|
GLP-1 and GLP-II; polysaccharide purity: 74.03% and 75.61% |
Intraperitoneal Injection of 30 mg/kg STZ in SD rats for 3 days | 200, 400 and 800 mg/kg for 16 weeks | Diabetic myocardial fibrosis | Attenuation of myocardial collagen crosslinking related to the decreased level of AGE and augmented activities of antioxidant enzymes | 2011 (Meng et al., 2011) |
|
GL-PS; crude polysaccharide |
Intraperitoneal injection of 100 mg/kg STZ in C57BL/6J mice for 2 days | 125 and 250 mg/kg for 8 weeks | Improvement of diabetic renal complications | Amelioration of metabolic disorders, oxidative stress and renal dysfunction associated with renal lesions | 2006 (He et al., 2006) |
|
GLPS; crude polysaccharide |
Intraperitoneal injection of 35 mg/kg STZ in SD mice for 3 days | 200, 400 and 800 mg/kg for 8 weeks | Diabetic myocardial fibrosis | Regulation of oxidative stress and reductions in the levels of AGEs and myocardial fibrosis | 2011 (Li, 2011) |
|
Intraperitoneal injection of 30 mg/kg STZ in SD mice for a week | 300 and 600 mg/kg for 12 weeks | Diabetic myocardial fibrosis | Strengthening of antioxidant enzyme activities and downregulated of myocardial CTGF | 2014 (Qiao et al., 2014) |
||
Phallus impudicus | PIP; Mycelium polysaccharide |
Full-thickness skin flap excision model in Wistar rats | Ointment containing 10% Phallus impudicus polysaccharides | Wound healing properties | Enhancement of healing with regards to epithelialization, contraction and growth of granulation tissue | 2019 (Vyacheslav et al., 2019) |
Tremella aurantialba | TMP; crude polysaccharide |
Intraperitoneal injection of 180 mg/kg alloxan in Wistar rats for 5 days | 100 mg/kg for 28 days | Abnormal lipid metabolism and elevated oxidative stress | Regulation of lipid metabolism and decreased oxidative stress | 2009 (Zhang et al., 2009) |